NMRA

NASDAQStock

Neumora Therapeutics, Inc. Common Stock

$3.04-0.10 (-3.18%)

52-Week Range

$0.62
$3.59

Key Stats

Market Cap

508.0M

P/E Ratio

Dividend Yield

Beta

2.53

Volume

460.9K

Avg Volume

862.0K

Performance

1M

-3.38%

3M

+60.20%

6M

+106.58%

YTD

+89.16%

1Y

+145.31%

3Y

-80.68%

5Y

-80.68%

Price Chart

ETF Exposure

NMRA is held by 18 ETFs

ETFFund NameWeight
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
BIBProShares - Ultra Nasdaq Biotechnology0.03%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.03%
IBBiShares Biotechnology ETF0.02%
SCHASchwab U.S. Small-Cap ETF0.01%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
VHTVanguard Health Care ETF0.00%
VXFVanguard Extended Market ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About NMRA ETF Exposure

Neumora Therapeutics, Inc. Common Stock (NMRA) is held by 18 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 508.0M, NMRA is a widely held institutional stock. The stock currently trades at $3.04. Investors can gain exposure to NMRA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NMRA, sorted by portfolio weight.